Catalyst Biosciences Inc Stock
Catalyst Biosciences Inc Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Catalyst Biosciences Inc.
With a target price of 23 € there is potential for a 4327.33% increase which would mean more than doubling the current price of 0.52 € for Catalyst Biosciences Inc.
Our community identified positive and negative aspects for Catalyst Biosciences Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Catalyst Biosciences Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Catalyst Biosciences Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Catalyst Biosciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Catalyst Biosciences Inc | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | -0.240% | 0.719% | 3.129% | -51.779% | 24.242% | -63.772% | -94.657% |
| Pacira Pharmaceuticals | -1.130% | 6.707% | 6.061% | -29.435% | -18.981% | -53.704% | -71.074% |
| Twist Bioscience Corp | -1.140% | 3.514% | 15.486% | -9.123% | 48.079% | 92.891% | -68.277% |
Comments
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating and a $35.00 price target on the stock.
Show more
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma (NASDAQ:CBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Show more
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $26.00 price target on the stock.
Show more
Ratings data for CBIO provided by MarketBeat